STD Testing and Management Following Condom Failure
Immediate Testing Panel
- The patient requires immediate comprehensive STD testing, including nucleic acid amplification tests (NAATs) for gonorrhea and chlamydia from all exposure sites, syphilis serology, HIV testing, and consideration for trichomonas testing, with follow-up testing at 2 weeks and 3 months for syphilis and HIV, given her high-risk history of multiple prior STIs, as recommended by the American College of Physicians and the CDC 1, 2, 3
- The Centers for Disease Control and Prevention (CDC) recommends HIV antibody testing with baseline serology 2, 5
- The CDC also recommends testing for trichomonas vaginalis NAAT from urine or vaginal specimen, particularly given her history of prior trichomoniasis infection 2, 4
- Hepatitis B surface antigen and antibody testing is recommended if vaccination status is unknown 5
Risk Stratification Justifying Comprehensive Testing
- The patient meets multiple high-risk criteria warranting aggressive screening, including history of previous gonorrhea, chlamydia, and trichomonas infections, as noted by the American College of Physicians 1, 7
- The American Congress of Obstetricians and Gynecologists recommends screening for gonorrhea in asymptomatic women at high risk, including those with previous STIs, new or multiple sex partners, and inconsistent condom use 1, 7
Follow-Up Testing Schedule
- The CDC recommends repeat testing at 2 weeks for gonorrhea, chlamydia, and trichomonas if initial tests were negative and no presumptive treatment was given 2, 5
- HIV and syphilis serology should be repeated at 6 weeks and 3 months 5
Presumptive Treatment Considerations
- The CDC recommends presumptive antibiotic treatment in settings where the likelihood of STD infection is high or prompt follow-up is uncertain 8
HIV Post-Exposure Prophylaxis (PEP) Consideration
- The CDC recommends evaluating the need for HIV PEP within 72 hours of exposure, with options including bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir plus tenofovir alafenamide plus emtricitabine for 28 days 2
Hepatitis B Prophylaxis
- The CDC recommends initiating hepatitis B vaccination series at the initial visit, with follow-up doses at 1-2 months and 4-6 months, if the patient is not vaccinated or immunity is uncertain 5
Critical Management Pitfalls to Avoid
- The CDC recommends retesting all patients diagnosed with chlamydial or gonococcal infections 3 months after treatment due to high likelihood of reinfection 1, 7, 3